Asia
AbbVie closed out 2018 by striking a nearly $1 billion licensing deal for India-based Lupin Limited’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
Follow-up investigations by the Wall Street Journal suggest that He Jiankui’s story may be just the tip of the iceberg of sloppy and unmonitored clinical trials using CRISPR in China.
In an endeavour to support development of Fertility and Reproductive Medicine in Oman, IVI Middle East Fertility Clinic Muscat– has organised a series of programmes for the medical community, in association with the Oman Society of Obstetrics and Gynecology
Move in line with ‘National Program for the Combat of Obesity in Children and Adolescents 2021'
Professor Jackie Y. Ying who heads A*STAR’s NanoBio Lab in Singapore has won the 2018 Turkish Academy of Sciences Academy Prize in Science and Engineering Sciences
The battle of the bulge is ongoing and it appears that Americans are losing, according to a report from the U.S. Centers for Disease Control and Prevention. The report shows that Americans are losing height and gaining girth.
As 2018 comes to a close, analysts, journalists, investors and industry-watchers are studying their crystal balls to see what trends to watch in the upcoming year. Here are 7 trends most likely to be hitting the news cycle.
Varicoceles can be found in 15 percent of the adult male population
With the holiday upon us, many companies in the pharma and biotech industry have made some important announcements – some big, some small. BioSpace has gathered a number of announcements that might have gone unnoticed and put them together below.
As news continues about Johnson & Johnson’s talcum powder containing carcinogenic asbestos, more than 100 drug inspectors in India are seizing samples, characterized The Times of India. The company, however, downplays that description, suggesting that the samples are fairly routine.
PRESS RELEASES